← Back to headlines
Denali Therapeutics Reports Q4 Earnings In-Line with Estimates
Denali Therapeutics announced its latest financial results, reporting a GAAP EPS of -$0.73, which was in-line with analyst estimates.
26 Feb, 22:06 — 26 Feb, 22:06
ℹOnly 1 source covers this story
